alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                          1,760,254
<SECURITIES>                                            0
<RECEIVABLES>                                     431,353
<ALLOWANCES>                                       16,000
<INVENTORY>                                     2,597,635
<CURRENT-ASSETS>                                3,580,547
<PP&E>                                          3,093,867
<DEPRECIATION>                                  1,688,428
<TOTAL-ASSETS>                                  7,138,444
<CURRENT-LIABILITIES>                             240,358
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                            6,147
<OTHER-SE>                                      3,914,508
<TOTAL-LIABILITY-AND-EQUITY>                    7,138,444
<SALES>                                        10,626,244
<TOTAL-REVENUES>                                3,298,529
<CGS>                                           3,030,003
<TOTAL-COSTS>                                   3,030,003
<OTHER-EXPENSES>                                7,104,208
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                    398
<INCOME-PRETAX>                                   223,109
<INCOME-TAX>                                       86,000
<INCOME-CONTINUING>                               137,109
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                      137,109
<EPS-BASIC>                                          0.02
<EPS-DILUTED>                                        0.02



</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; Alzheimer's Disease Drug Development.                    

*Date:*                         January 18, 2024.                    

*Time:*                         12:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, RM: 2E400, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Mariel Jais, Ph.D., M.D.,  Scientific Review Officer, Scientific Review Branch, National Institutes of Health, National Institute on Aging, 7201 Wisconsin Avenue, RM: 2E400, Bethesda, MD 20892, (301) 594-2614,                         *mariel.jais@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: December 8, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-27424 Filed 12-13-23; 8:45 am]

BILLING CODE 4140-01-P
Inspection Items to Consider (electronic desk file on the Mail Log)

ICWI0067.01 Page 2 of 2

Author: Renee M. Schnurr

Issue Date: 11Jun15

Source Document and Date of Issue or Edition: ICSOP0012, Pre-Inspection Activities

This Tag does not require the item to be inspected during the on-site inspection, but may be a 

part of the pre-inspection process to prepare for the inspection. Also, this does not child loop or 

move the document forward, it only tags the document for review during the pre-inspection 

process. 

HOW TO CREATE “desk file” REPORT for pre-inspection review

1. Go to Mail

2. Searching

3. Master Search

4. Enter 

Establishment

Date Submitted From (date of last inspection) To: (current date)

Tag: Inspection Item to Consider

5. Click on Search

6. Click on Excel spreadsheet and customize as needed

If there are questions as to why an item is tagged, please consult with the document author 

during the pre-inspection review.
Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

The undersigned executive officers of Ameriana Bancorp (the Registrant) hereby certify that this Annual Report on Form 10-K for the year ended December 31, 2006 (the Report) fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.



|                     |  |        |  |                                           
|-------------------- |  | ------ |  | ------------------------------------------
|                     |  | By:    |  | /s/ Jerome J. Gassen                      
|                     |  | Name:  |  | Jerome J. Gassen                          
|                     |  | Title: |  | President and Chief Executive Officer     
|                     |  |       
|                     |  | By:    |  | /s/ John J. Letter                        
|                     |  | Name:  |  | John J. Letter                            
|                     |  | Title: |  | Principal Financial and Accounting Officer
|                     |  |       
|Date: March 28, 2007 |  |        |  |
# C_2018112EN.01003701.xml

| 26.3.2018 | EN | Official Journal of the European Union | C 112/37 |
| --- | --- | --- | --- |

26.3.2018

EN

Official Journal of the European Union

C 112/37

---

Action brought on 23 January 2018 — Pracsis and Conceptexpo Project v Commission and EACEA

(Case T-33/18)

(2018/C 112/48)

Language of the case: French

Parties

Parties

Applicants: Pracsis SPRL (Brussels, Belgium) and Conceptexpo Project (Wavre, Belgium) (represented by: J.-N. Louis, lawyer)

Applicants:

Defendants: European Commission and Education, Audiovisual and Culture Executive Agency (EACEA)

Defendants:

Form of order sought

Form of order sought

The applicants claim that the General Court should:

| — | declare the action admissible and well founded; |
| --- | --- |

—

declare the action admissible and well founded;

| — | annul the contested decisions, in that they designate Cecoforma as the successful tenderer for the framework contract of the call for tenders EACEA/2017/01, and annul the contract signed between EACEA and Cecoforma; |
| --- | --- |

—

annul the contested decisions, in that they designate Cecoforma as the successful tenderer for the framework contract of the call for tenders EACEA/2017/01, and annul the contract signed between EACEA and Cecoforma;

| — | order the European Commission and EACEA, jointly and severally, to pay to the applicants the sum of EUR 1 million; |
| --- | --- |

—

order the European Commission and EACEA, jointly and severally, to pay to the applicants the sum of EUR 1 million;

| — | order the defendants to pay the costs. |
| --- | --- |

—

order the defendants to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicants rely on three pleas in law.

| 1. | First plea in law, alleging infringement of the principle of equal treatment and of the duty of transparency. |
| --- | --- |

1.

First plea in law, alleging infringement of the principle of equal treatment and of the duty of transparency.

| 2. | Second plea in law, alleging infringement of the right to be heard. |
| --- | --- |

2.

Second plea in law, alleging infringement of the right to be heard.

| 3. | Third plea in law, alleging breach of the obligation to state reasons and a manifest error of assessment. |
| --- | --- |

3.

Third plea in law, alleging breach of the obligation to state reasons and a manifest error of assessment.

---
CSB BANCORP, INC.EXHIBIT 31.1Rule 13a-14(a)/15d-14(a) CertificationPresident and Chief Executive OfficerI, Eddie L. Steiner, certify that: 1. I have reviewed this quarterly report on Form 10-Q of CSB Bancorp, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made,in light of the circumstances under which such statements were made, not misleadingwith respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in ExchangeAct Rules 13a-15(e) and 15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’smost recent fiscal quarter that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and 5. The registrant’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board of directors(or persons performing the equivalent functions): 
22.

 
CSB BANCORP, INC. a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and  b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrol over financial reporting.Date: November 12, 2007       /s/ Eddie L. Steiner Eddie L. Steiner    President and    Chief Executive Officer   
23.
18932

#### State v. Vela

April 16, 1997

Order No. 97-37

Affirmed
An Equal Opportunity Provider and Employer

CENTER FOR VETERINARY BIOLOGICS NOTICE NO. 23-15

TO: Biologics Licensees, Permittees, and Applicants

Directors, Center for Veterinary Biologics

Veterinary Services Leadership Team

FROM: Geetha Srinivas, DVM, PhD

Director

SUBJECT: Issuance of a Conditional License for Rabbit Hemorrhagic Disease Virus

The Animal and Plant Health Inspection Service (APHIS) has issued a conditional 

United States Veterinary Biological Product License to Medgene Labs, Establishment 

No. 474, Brookings, South Dakota, for the manufacture and distribution of Rabbit 

Hemorrhagic Disease Vaccine, Serotype 2, Killed Baculovirus Vector.

A veterinary biological product regulated under the Virus-Serum-Toxin Act must be 

shown to be pure, safe, potent, and efficacious before a veterinary biological product 

license may be issued. The regulations in title 9, Code of Federal Regulations, part 102, 

regarding the licensing of veterinary biological products provide that a conditional 

veterinary biological product license may be issued to meet an emergency condition, 

limited market, local situation, or special circumstance. The special circumstance 

addressed here is disease in rabbits caused by Rabbit Hemorrhagic Disease Virus.

Conditionally licensed products are required to be pure and safe, and have a reasonable 

expectation of efficacy. This conditional license was issued on the basis that the 

licensee has demonstrated that the product has a reasonable expectation of efficacy. 

APHIS will evaluate their progress throughout the next year. The conditional license 

will expire one year from the date of the license.

Animal and Plant

Health Inspection

Service

Veterinary Services

Center for Veterinary

Biologics

1920 Dayton Avenue

PO Box 844

Ames, IA 50010

(515) 337-6100
<PAGE>


                                                                    EXHIBIT 99.2

     CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K for the period ended December
31, 2002, of Magnum Hunter Resources, Inc., as filed with the Securities and
Exchange Commission on the date hereof, the undersigned hereby certifies,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

1.        this annual report on Form 10-K fully complies with the requirements
          of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
          amended; and

2.        the information contained in this annual report on Form 10-K fairly
          presents, in all material respects, the financial condition and
          results of operations of Magnum Hunter Resources, Inc.

/s/ Chris Tong
------------------------------------
Chris Tong
Senior Vice President
and Chief Financial Officer
(principal accounting officer)

Date: March 26, 2003
September 13, 2000

22549

#### State v. Armitage

Affirmed
```

[Congressional Record Volume 158, Number 112 (Wednesday, July 25, 2012)]
[House]
[Page H5292]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

           By Ms. WATERS:
       H.R. 6204.
       Congress has the power to enact this legislation pursuant 
     to the following:
       Article I, Section 8, Clause 3
       The Congress shall have Power * * * To regulate Commerce 
     with foreign Nations, and among the several States, and with 
     the Indian Tribes.
```
#### Jesus C. HERNANDEZ, Individually and as the surviving father of Sergio Adrian Hernandez Guereca, and as Successor-in-Interest to the Estate of Sergio Adrian Hernandez Guereca; Maria Guadalupe Guereca Bentacour, Individually and as the surviving mother of Sergio Adrian Hernandez Guereca, and as Successor-in-Interest to the Estate of Sergio Adrian Hernandez, Plaintiffs-Appellants v. Jesus MESA, Jr., Defendant-Appellee

No. 12-50217

United States Court of Appeals, Fifth Circuit.

FILED July 26, 2017

*358Robert C. Hilliard, Esq., Rudy 0. Gonzales, Jr., Marion M. Reilly, Hilliard Munoz Gonzales, L.L.P., Corpus Christi, TX, Cristobal Miguel Galindo, Attorney, Houston, TX, Steve D. Shadowen, Esq., Hilliard Shadowen, L.L.P., Austin, TX, for Plaintiffs-Appellants.

Katherine Twomey Allen, Helen Louise Gilbert, Esq., Henry Charles Whitaker, U.S. Department of Justice, Civil Division, Appellate Section, Washington, DC, Harold Edwin Brown, Jr., Esq., Assistant U.S. Attorney, U.S. Attorney’s Office, Western District of Texas, San Antonio, TX, Zachary Carl Richter, Assistant U.S. Attorney, U.S. Attorney’s Office, Western District of Texas, Austin, TX, Randolph Joseph Ortega, Esq., Ellis & Ortega, Louis Elias Lopez, Jr., Esq., Law Office of Louis E. Lopez, El Paso, TX, for Defendants-Appellees.

Esha Bhandari, American Civil Liberties Union Foundation of New York, Lee P. Gelernt, Esq., American Civil Liberties Union Foundation, Immigrants’ Rights Project, New York, NY, Alexandra Freedman Smith, American Civil Liberties Union of New Mexico, Albuquerque, NM, Ce-cillia D. Wang, American Civil Liberties Union Foundation, Immigrants’ Rights Project, San Francisco, CA, for Amici Curiae American Civil Liberties Union Foundation, American Civil Liberties Union Foundation of Arizona, American Civil Liberties Union Foundation of New Mexico, American Civil Liberties Union Foundation of Texas, American Civil Liberties Union Foundation of San Diego *&*Imperial Counties.

Nancy Winkelman, Attorney, Schnader, Harrison, Segal *&*Lewis, L.L.P., Philadelphia, PA, for Amici Curiae Border Network for Human Rights, Paso Del Norte Civil Rights Project, Southern Border Communities Coalition.

Donald Francis Donovan, Esq., Senior Counsel, Carl Jonas Micarelli, Debevoise & Plimpton, L.L.P., New York, NY, for Amicus Curiae Government of the United Mexican States.

Guinevere Elizabeth Moore, Pro se.

Guinevere Elizabeth Moore, Teague, TX, for Amicus Curiae Robert T. Moore.

Before STEWART, Chief Judge, JOLLY, DAVIS, JONES, SMITH, DENNIS, CLEMENT, PRADO, OWEN, ELROD, SOUTHWICK, HAYNES, GRAVES, HIGGINSON and COSTA, Circuit Judges.

BY THE COURT:

IT IS ORDERED that this cause shall be reheard by the court en banc with oral argument on September 20, 2017. Briefing instructions will follow in a separate court directive.
H. Res. 809 

In the House of Representatives, U. S., 

July 7, 2016. 

Resolved, That upon adoption of this resolution it shall 

be in order to consider the conference report to accompany 

the bill (S. 524) to authorize the Attorney General to award 

grants to address the national epidemics of prescription 

opioid abuse and heroin use. All points of order against the 

conference report and against its consideration are waived. 

The conference report shall be considered as read. The previous question shall be considered as ordered on the conference report to its adoption without intervening motion except: (1) one hour of debate; and (2) one motion to recommit 

if applicable. 

SEC. 2. Upon adoption of this resolution— 

(a) the House shall be considered to have: (1) taken 

from the Speaker’s table the bill (S. 2943) to authorize appropriations for fiscal year 2017 for military activities of the 

Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe 

military personnel strengths for such fiscal year, and for 
2 

•HRES 809 EH 

other purposes; (2) stricken all after the enacting clause of 

such bill and inserted in lieu thereof the provisions of H.R. 

4909, as passed by the House; and (3) passed the Senate bill 

as so amended; and 

(b) it shall be in order for the chair of the Committee 

on Armed Services or his designee to move that the House 

insist on its amendment to S. 2943 and request a conference 

with the Senate thereon. 

Attest: 

Clerk.
# C_2018161EN.01005501.xml

| 7.5.2018 | EN | Official Journal of the European Union | C 161/55 |
| --- | --- | --- | --- |

7.5.2018

EN

Official Journal of the European Union

C 161/55

---

Action brought on 28 February 2018 — LMP Lichttechnik Vertriebs v EUIPO (LITECRAFT)

(Case T-140/18)

(2018/C 161/63)

Language of the case: German

Parties

Parties

Applicant: LMP Lichttechnik Vertriebs GmbH (Ibbenbüren, Germany) (represented by: R. Plegge, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Trade mark at issue: European Union word mark ‘LITECRAFT’ — Application for registration No 15 282 635

Trade mark at issue:

Contested decision: Decision of the Second Board of Appeal of EUIPO of 8 January 2018 in Case R 699/2017-2

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Plea in law

Plea in law

| — | Infringement of Article 7(1)(b) and (c) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 7(1)(b) and (c) of Regulation No 207/2009.

---
Chapter 2.4.4. – Infection with Marteilia refringens

Annex 37. Item 6.8. – Article 10.6.2. of Chapter 10.6. ‘Infection with infectious haematopoietic necrosis virus’

CHAPTER 10.6.

INFECTION WITH INFECTIOUS HAEMATOPOIETIC NECROSIS VIRUS

[...]

Article 10.6.2.

Scope

The recommendations in this chapter apply to the following species that meet the criteria for listing as susceptible in accordance with Chapter 1.5.: ~~Arctic charr (*Salvelinus alpinus*), Atlantic salmon (*Salmo salar*), brook trout (*Salvelinus fontinalis*), brown trout (*Salmo trutta*), chinook salmon (*Oncorhynchus tshawytscha*), chum salmon (*Oncorhynchus keta*), coho salmon (*Oncorhynchus kisutch*), cutthroat trout (*Onchorynchus clarkii*), lake trout (*Salvelinus namaycush*), masu salmon (*Oncorhynchus masou*), marble trout (*Salmo marmoratus*), pike (*Esox lucius*), rainbow trout (*Oncorhynchus mykiss*) and sockeye salmon (*Oncorhynchus nerka*).~~

[...]

____________

WOAH *Aquatic Manual* 2025	8
#### Vondra et al., Appellants, v. City *of*Cleveland et al., Appellees.

(No. 32017

Decided January 25, 1950.)

*Mr. Irwin Greene,*for appellants.

*Mr. Lee G. Howley,*director of law, *Mr. Robert J. Reiser*and *Mr. Edward F. McDermott,*for appellees.

It is ordered and adjudged that this appeal as of right he, and the same hereby is, dismissed for the reason that no debatable constitutional question is involved.

*Appeal dismissed.*

Weygandt, C. J., Matthias, Hast, Zimmebman, Stewabt, Ttjbnee and Tapt, JJ., concur.